# Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia

> **NCT03703271** · PHASE3 · UNKNOWN · sponsor: **Women's Hospital School Of Medicine Zhejiang University** · enrollment: 214 (estimated)

## Conditions studied

- Gestational Trophoblastic Neoplasia

## Interventions

- **DRUG:** Methotrexate
- **PROCEDURE:** hysteroscopic repeat curettage

## Key facts

- **NCT ID:** NCT03703271
- **Lead sponsor:** Women's Hospital School Of Medicine Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 214 (ESTIMATED)
- **Last updated:** 2022-07-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03703271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03703271, "Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03703271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*